FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

38234511000001107: Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Apr 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1292481000001111 Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1292491000001113 Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has specific active ingredient Ritonavir true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has specific active ingredient Lopinavir true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Has AMP Kaletra 200mg/50mg tablets (Abbott Laboratories Ltd) true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Is a Lopinavir 200mg / Ritonavir 50mg tablets 120 tablet true Inferred relationship Existential restriction modifier
Kaletra 200mg/50mg tablets (AbbVie Ltd) 120 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start